Read more
14:50 · 19 October 2023

BREAKING: EU approves Pfizer's prposed acqusition of Seagen!

Seagen
Shares
SGEN.US, Seattle Genetics Inc
-
-
Pfizer
Shares
PFE.US, Pfizer Inc
-
-

Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs. 

Source: xStation5 

3 December 2025, 17:47

Microsoft shares recover losses sparked by fears of weaker demand for AI products 🔎

3 December 2025, 13:10

DE40: Europe maintains narrow consolidation

3 December 2025, 12:04

Light in Data Centers: Marvell Bets on AI

3 December 2025, 09:52

UK service sector surprises on the upside, but activity remains subdued

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Join over 2 Million investors from around the world